Rayner – a global manufacturer of products for cataract surgery based in the UK – unveiled the world’s first spiral IOL at the ESCRS congress in Barcelona.
The RayOne Galaxy and RayOne Galaxy Toric are now available in Australia and many other markets around the world after the company announced their commercial release.
The Galaxy is TGA registered but does not yet have healthcare reimbursement in Australia. The company says it is working on that.
A media release said RayOne Galaxy “sets a new standard for what surgeons can offer their premium lens replacement patients”.
“Developed with AI, its unique non-diffractive spiral optic delivers a smooth and continuous full range of vision with minimised dysphotopsia and 0% loss of transmitted light.”
As part of the work leading up to the launch 10 leading surgeons from 10 countries conducted a clinical evaluation, with more than 180 eyes treated with RayOne Galaxy and RayOne Galaxy Toric – collecting postoperative clinical outcomes at one and three months.
Interim outcomes showed that RayOne Galaxy and RayOne Galaxy Toric provide:
- A full range of vision, without the wave-like defocus pattern associated with diffractive trifocal IOLs.
- Mean corrected and uncorrected visual acuities at all distances of 0.1 logMAR or better.
- Binocular defocus curve VA of 0.2 logMAR or better across a ~4.0 D range.
- Less halo and glare compared to published data on diffractive trifocal IOLs.
- In a pre-clinical study of 30 subjects with healthy eyes, RayOne Galaxy demonstrated a halo size closer to that of an enhanced monofocal IOL than a diffractive trifocal IOL.
Dr Francesco Carones, who took part in the initial clinical evaluation, said: “I have had the opportunity to implant RayOne Galaxy during Rayner’s pre-launch clinical phase, and it was immediately apparent that this IOL can provide a very long range of focus with minimal compromises on the quality of night vision.
“I think this IOL represents a significant step forward in the technologies available to provide patients with very reduced spectacle dependence following lens replacement for cataract or refractive purposes.”
Rayner CEO Mr Tim Clover said: “With over 6,000 lenses now in the market, we want to thank everyone who has placed their trust in our new lens technology.
“The response and enthusiasm from our customers around the world has been phenomenal and we look forward to seeing more patients achieving excellent results with the world’s first spiral IOL.”
The RayOne Galaxy spiral IOL platform is now available to all surgeons, subject to local regulatory approval.
Those keen to know more can visit www.rayner.com/Galaxy.
More reading
Early impressions with new spiral IOL from Rayner
Rayner RayOne Galaxy ‘world’s first spiral IOL’
Rayner’s history of charting new territory
